Sort
16,300 grants matching “fatty liver disease”
Mechanisms of Liver Cell Injury
$12,395Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2010 · DK
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
$12,250Parvathi Mohan · Children'S Research Institute · M01 · FY2009 · RR
Regulation of Hepatic Lipid and Glucose Metabolism by Phosphatidylcholine Transfe
$12,232David E Cohen · Brigham And Women'S Hospital · R01 · FY2009 · DK
Expression and Post-translational Modification of Cytochrome P450 4A11 Variants in Modulation of Blood Pressure Through Regulation of 20-Hydroxyeicosatetraenoic Acid (20-HETE) Production
$12,155Matthew Edward Albertolle · Vanderbilt University · F31 · FY2018 · HL
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)
$12,136Arun J Sanyal · Virginia Commonwealth University · M01 · FY2008 · RR
METABOLIC EFFECTS OF ANTIPSYCHOTICS IN CHILDREN
$12,065John W. Newcomer · Washington University · M01 · FY2007 · RR
HEP DART 2021: FRONTIERS IN DRUG DEVELOPMENT FOR HEPATOLOGY
$12,000Raymond F. Schinazi · Emory University · R13 · FY2022 · AI
FASEB's "The Intestinal Lipid Metabolism Conference: In Health and Disease"
$12,000Chi- Liang Eric Yen · Federation Of Amer Soc For Exper Biology · R13 · FY2021 · DK
Fatty Liver Disease and Multi-System Complications
$12,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2021 · DK
Guanylyl cyclase receptors: Targets for medical intervention
$11,894Joseph P Albanesi · Ut Southwestern Medical Center · R01 · FY2007 · DK
USE OF A NOVEL INTRAVENOUS FAT PREPARATION IN THE MANAGEMENT OF INFANTS
$11,865Steven A Abrams · Baylor College Of Medicine · M01 · FY2009 · RR
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$11,741Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2014 · HL
NON-ALCOHOLIC FATTY LIVER DISEASE, ETHNICITY AND HEPATIC METABOLISM
$11,740Jeff L Browning · Ut Southwestern Medical Center · P41 · FY2006 · RR
Role of UCP1 in the inter-organ lipid cycle engaged by dietary methionine restric
$11,649Desiree Wanders · Lsu Pennington Biomedical Research Ctr · F32 · FY2015 · DK
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
$11,637Naga P. Chalasani · Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2007 · RR
MITOCHONDRIAL SHORT CHAIN 3-OH-ACYL-COA DEHYDROGENASES
$11,588Washington University · R01 · FY2000 · DK
Role of Stearoyl-CoA Desaturase in Metabolism
$11,417James M. Ntambi · University Of Wisconsin-Madison · R01 · FY2009 · DK
CLINICAL TRIAL: TREATMENT OF NONALCOHOLIC STEATOHEPATITIS IN CHILDREN (TONIC)
$11,377Stephanie H Abrams · Baylor College Of Medicine · M01 · FY2008 · RR
Investigating Branched Chain Amino Acid Oxidation in Skeletal Muscle and its Contribution to Insulin Resistance
$11,369Megan Chandler Blair · University Of Pennsylvania · F31 · FY2023 · DK
The role of insulin signaling in the dyslipidemia of the metabolic syndrome
$11,280Sudha B Biddinger · Joslin Diabetes Center · R03 · FY2009 · DK
H-MAGNETIC RESONANCE SPECTROSCOPY FOR QUANTIFYING MYOCARDIAL LIPID
$11,261Robert O'Conner · Washington University · P41 · FY2010 · RR
Pilot Project
$11,254Pierre Michel Gholam · Cleveland Clinic Lerner Com-Cwru · P20 · FY2012 · AA
Integrated Regulation of Bile Acids and Diabetes
$11,000Timothy F Osborne · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · DK
FFA Metabolism, Insulin Resistance and Type 2 Diabetes
$10,824University Of Texas Hlth Sci Ctr San Ant · F32 · FY2003 · DK
Environmental Exposure and Cardiometabolic Disease
$10,800Sanjay Srivastava · University Of Louisville · P42 · FY2020 · ES